262 related articles for article (PubMed ID: 18708356)
1. Small ubiquitin-related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification.
Zhu J; Zhu S; Guzzo CM; Ellis NA; Sung KS; Choi CY; Matunis MJ
J Biol Chem; 2008 Oct; 283(43):29405-15. PubMed ID: 18708356
[TBL] [Abstract][Full Text] [Related]
2. Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1.
Zhu S; Goeres J; Sixt KM; Békés M; Zhang XD; Salvesen GS; Matunis MJ
Mol Cell; 2009 Mar; 33(5):570-80. PubMed ID: 19285941
[TBL] [Abstract][Full Text] [Related]
3. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
4. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
Citro S; Chiocca S
Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
[TBL] [Abstract][Full Text] [Related]
5. SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis.
Zhang XD; Goeres J; Zhang H; Yen TJ; Porter AC; Matunis MJ
Mol Cell; 2008 Mar; 29(6):729-41. PubMed ID: 18374647
[TBL] [Abstract][Full Text] [Related]
6. Covalent modification of the Werner's syndrome gene product with the ubiquitin-related protein, SUMO-1.
Kawabe Y; Seki M; Seki T; Wang WS; Imamura O; Furuichi Y; Saitoh H; Enomoto T
J Biol Chem; 2000 Jul; 275(28):20963-6. PubMed ID: 10806190
[TBL] [Abstract][Full Text] [Related]
7. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
8. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy.
Matic I; van Hagen M; Schimmel J; Macek B; Ogg SC; Tatham MH; Hay RT; Lamond AI; Mann M; Vertegaal ACO
Mol Cell Proteomics; 2008 Jan; 7(1):132-44. PubMed ID: 17938407
[TBL] [Abstract][Full Text] [Related]
9. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
Eisenhardt N; Chaugule VK; Pichler A
Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
[TBL] [Abstract][Full Text] [Related]
10. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification.
Sampson DA; Wang M; Matunis MJ
J Biol Chem; 2001 Jun; 276(24):21664-9. PubMed ID: 11259410
[TBL] [Abstract][Full Text] [Related]
11. SUMOylation regulates polo-like kinase 1-interacting checkpoint helicase (PICH) during mitosis.
Sridharan V; Park H; Ryu H; Azuma Y
J Biol Chem; 2015 Feb; 290(6):3269-76. PubMed ID: 25564610
[TBL] [Abstract][Full Text] [Related]
12. MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity.
Stindt MH; Carter S; Vigneron AM; Ryan KM; Vousden KH
Cell Cycle; 2011 Sep; 10(18):3176-88. PubMed ID: 21900752
[TBL] [Abstract][Full Text] [Related]
13. Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design.
Gilbreth RN; Truong K; Madu I; Koide A; Wojcik JB; Li NS; Piccirilli JA; Chen Y; Koide S
Proc Natl Acad Sci U S A; 2011 May; 108(19):7751-6. PubMed ID: 21518904
[TBL] [Abstract][Full Text] [Related]
14. Converging Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Signaling: Improved Methodology Identifies Co-modified Target Proteins.
Cuijpers SAG; Willemstein E; Vertegaal ACO
Mol Cell Proteomics; 2017 Dec; 16(12):2281-2295. PubMed ID: 28951443
[TBL] [Abstract][Full Text] [Related]
15. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1.
Desterro JM; Rodriguez MS; Kemp GD; Hay RT
J Biol Chem; 1999 Apr; 274(15):10618-24. PubMed ID: 10187858
[TBL] [Abstract][Full Text] [Related]
16. Small ubiquitin-related modifiers in chains.
Vertegaal AC
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1422-3. PubMed ID: 18031236
[TBL] [Abstract][Full Text] [Related]
17. Small ubiquitin-related modifier paralogs are indispensable but functionally redundant during early development of zebrafish.
Yuan H; Zhou J; Deng M; Liu X; Le Bras M; de The H; Chen SJ; Chen Z; Liu TX; Zhu J
Cell Res; 2010 Feb; 20(2):185-96. PubMed ID: 19704416
[TBL] [Abstract][Full Text] [Related]
18. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.
Schimmel J; Larsen KM; Matic I; van Hagen M; Cox J; Mann M; Andersen JS; Vertegaal AC
Mol Cell Proteomics; 2008 Nov; 7(11):2107-22. PubMed ID: 18565875
[TBL] [Abstract][Full Text] [Related]
19. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
20. Molecular features of human ubiquitin-like SUMO genes and their encoded proteins.
Su HL; Li SS
Gene; 2002 Aug; 296(1-2):65-73. PubMed ID: 12383504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]